期刊文献+

雄激素受体对人乳腺癌细胞侵袭和迁移影响的研究 被引量:11

The effect of androgen receptor on migration and invasion of human breast cancer cells
下载PDF
导出
摘要 目的:探讨雄激素受体(Androgen receptor,AR)对人三阴性乳腺癌细胞侵袭和迁移的影响。方法:采用Real-time Q-PCR检测七株人乳腺癌细胞中AR的表达,AR敲低后,通过细胞迁移实验及细胞免疫荧光观察AR敲低对乳腺癌细胞迁移力及细胞表面黏着斑形成的影响;乳癌细胞采用AR阻断剂比卡鲁胺(Bicalutamide)处理后,通过细胞迁移实验、Transwell小室检测Bicalutamide对细胞侵袭和迁移力的影响。结果:AR在三阴性乳癌细胞中高表达;AR敲低能明显降低乳腺癌细胞的迁移力,并且明显抑制细胞表面黏着斑的形成;细胞迁移实验及侵袭实验显示AR阻断剂可显著抑制乳腺癌细胞的迁移和侵袭(P<0.01)。结论:AR shRNA及AR阻断剂能明显抑制人乳腺癌细胞的侵袭、迁移及黏着斑的形成。 Objective To evaluate the influence of androgen receptor (AR) on the migration and invasion of human triple-negative breast cancer cells. Methods Real-time Q-PCR was performed to detect the AR expression in 7 cell line of breast cancer. The effect of AR knockdown on migration and focal adhesion formation of breast cancer cells were assessed by cell migration and immunofluorescence assay. Breast cancer cells was treated with AR antagonist Migration assay and transwell migration assay were performed to detect the migration and invasion of treated cells. Results AR was highly expressed in triple-negative breast cancer cells. AR knockdown dramatically decreased the migration and inhibited large focal adhesion (FA) formation in. Migration and invasion assay showed that AR antagonist also inhibit the migration and invasion of breast cancer cells (P 〈 0.001). Conclusions AR knockdown and antagonistdramatically inhibit the migration.invasion and FA formation of human triple-negative breast cancer cells.
出处 《实用医学杂志》 CAS 北大核心 2014年第8期1189-1193,共5页 The Journal of Practical Medicine
基金 深圳市科技计划基金资助项目(编号:200802102)
关键词 雄激素受体 细胞侵袭 细胞迁移 黏着斑 Androgen receptor Invasion Migration Focal adhesion
  • 相关文献

参考文献9

  • 1吴珏堃,唐勇.SIAH2在乳腺癌发生、发展过程中的作用[J].实用医学杂志,2012,28(22):3761-3763. 被引量:3
  • 2Mehlen P, Puisieux A. Metastasis: a question of life or death [ J ]. Nat Rev Cancer, 2006,6 (16) : 449-458.
  • 3Huggins C, Hodges CV. Studies on prostatic cancer: The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941 [J]. J Urol, 2002,168 ( 1 ) : 9-12.
  • 4洪雷,魏素菊,邢晓英.三阴乳腺癌患者259例临床病理特征及预后分析[J].实用肿瘤学杂志,2013,29(15):2526-2529.
  • 5Li X, Zhou Q, Sunkara M. Ubiquitylation of phosphatidylino- sitol 4-phosphate 5-kinase type I gamma by HECTD1 regulates focal adhesion dynamics and cell migration [J]. J Cell Sci, 2013,126 (12) :2617-2628.
  • 6Shah PD, Gucalp A, Traina TA. The role of the androgen receptor in triple-negative breast cancer [J]. Womens Health (Lond Engl), 2013,9(4) : 351-360.
  • 7Mrklic I, Pogorelic Z, Capkun V, et al. Expression of androgen receptors in triple negative breast carcinomas [J]. Acta Histoehem, 2013,115 (4) : 344-348.
  • 8Gucalp A, Tolaney S, Isakoff SJ, et al. Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer [J]. Clin Cancer Res, 2013,19(19) : 5505-5512.
  • 9Dirac AM, Bernards R. The deubiquitinating enzyme USP26 is a regulator of androgen receptor signaling [J]. Mol Cancer Res, 2010,8(6) : 844-854.

二级参考文献11

  • 1Coughlin S S, Ekwueme D U. Breast cancer as a global heahh concern [J].Cancer Epidemiol, 2009,33 (5) : 315-318.
  • 2R~led J C,Ely K R.Degrading liaisons:Siah struclure revealed [J]. Nat Struct Biol, 2002,9 ( 1 ) : 8-10.
  • 3Nakay area K, Frew 1 J, Hagensen M, et al. Siah2 regulates stability of pmly-lhydroxylases,controls HlFl-alpha abundance and modulates physiological responses to hypoxia [J]. Cell, 2004,117(7) :941-952.
  • 4Holloway A J, Della N G, Fletcher C F, et al. Chromosomal mapping of five highly conselwed murine homologues of Ihe Drosophila RING finger gene seven-in-absentia [J]. Genomics. 1997, 41(2): 160-168.
  • 5Nadeau R J,Toher J L,Yang X,et al. Regulalion of Spmuty2 stability by mammalian Seven-in-Absentia homolog 2 [J]. (Jell Biochem, 2007, 100( 1 ) : 151-160.
  • 6Hacohen N, Kramer S.Sulherland D,el al. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways [J]. Cell. 1998, 92( 2 ) : 2.53-263.
  • 7Gross 1, Bassit B, Benezra M, el al. Mammalian sprouty proleins inhibit cell growth and differentiation by preventing ras activation [J]. Biol Chem, 2001,276 (49) : 46460-46468.
  • 8Qi j, Nakayama K, aitonde S, et al. The ubiquitin tigase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and independent pathways [J].Proc Natl Aead Sei USA,2008, 105(43) : 16713-16718.
  • 9Epstein A C, Gleadle J M, McNeill L A, et al. C.elegans EGL-9 and mammalian homolngs define a family of dioxygenases lhat regulate HIF by prolyl hy&oxyla6on [J]. Cell ,2001,107( 1 ):43-54.
  • 10Shah M, Stebbins J L, Dewing A, et al. Inhibition of Siah2 ubiquitin ligase by, vitamin K3 (menadione)altenaales h~poxia and MAPK signaling amt blocks melanoma tumorigenesis [J]. Pigment Cell Melanoma Res, 2009,22 (6) : 799-808.

共引文献2

同被引文献114

  • 1顾慧儿,吴香玫,赵淑敏,陶珍.氟喹诺酮类药物氟含量测定方法比较[J].中国医药工业杂志,1994,25(10):448-449. 被引量:8
  • 2刘雅茹,冯雪松,郭晓明.HPLC法测定比卡鲁胺含量[J].广东药学院学报,2005,21(6):681-682. 被引量:5
  • 3周新荣.2005版药典氟检查的原理及注意事项[J].黑龙江医药,2006,19(6):488-488. 被引量:1
  • 4韩雪松,胡勇,徐琳.性激素及相关基因多态与子宫内膜癌患病风险[J].国外医学(妇产科学分册),2007,34(6):424-427. 被引量:2
  • 5Qi Ji - ping. Expression of the androgen receptor and its correlationwith molecular subtypes in 980 Chinese breast cancer patients[ J].Breast Cancer,2012,6: 1 -8.
  • 6He Jiehua. Prognostic value of androgen receptor expression in op-erable triple - negative breast cancer : A retrospective analysis basedon a tissue microarray[ J]. Med Oncol,2012,29(2) :406 -410.
  • 7Gasparini Pierluigi. Androgen receptor status is a prognostic markerin non - basal triple negative breast cancers and determines noveltherapeutic options[ J]. PloS One,2014,9(2) :e88525 -88528.
  • 8Sutton Lisa M. Decreased androgen receptor expression is associat-ed with distant metastases in patients with androgen receptor - ex-pressing triple - negative breast carcinoma [ J ] . Am J Clin Pathol,2012,138(4) :511 -516.
  • 9Witzel,Isabell. Androgen receptor expression is a predictive mark-er in chemotherapy - treated patients with endocrine receptor -positive primary breast cancersf J]. J Cancer Res,2013,139(5):809 -816.
  • 10Lehmann BD,Pietenpol JA.Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes[J].J Pathol,2014,232(2):142-150.

引证文献11

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部